Sudeep Pharma IPO Subscription History

As of November 28, 2025, the Sudeep Pharma IPO has been subscribed 93.72 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest.

The Sudeep Pharma IPO subscription window was open from November 21, 2025 to November 25, 2025. Investors could apply through their demat account or ASBA facility.

The Sudeep Pharma IPO has a price band of ₹563 to ₹593 per share, with a lot size of 25 shares. Minimum retail investment: ₹14,075 (lower band) or ₹14,825 (upper band).

The QIB category has been subscribed 213.08 times. QIBs were offered 3,018,550 shares. Strong QIB subscription indicates high institutional confidence.

Retail investors subscribed 15.65 times. Retail was offered 5,282,463 shares. High retail subscription reflects strong small-investor interest.

Overall NII: 116.72×. bNII (>₹10L): 134.91×, sNII (<₹10L): 80.33×. NII includes HNIs and corporate entities investing above ₹2 lakh.

Basis of allotment is on November 26, 2025. Check via the registrar's website, MUFG Intime India Pvt.Ltd using your PAN number, application number, or DP/Client ID. You can also check on BSE/NSE websites or through your broker's app.

Sudeep Pharma IPO is expected to list on November 28, 2025. Shares will list on NSE,BSE. Allotted shares are credited to your demat account 1 business day before listing.

A subscription multiple of 93.72× means investors have bid for 93.72 times the total shares available. Since the IPO is oversubscribed, not every applicant will receive shares, allotment happens via lottery (for retail) or proportionately (for other categories). Higher multiples generally reduce allotment probability.

Based on the current retail subscription of 15.65×, the estimated allotment probability for retail investors is Low–Moderate. Lottery-based allotment. Retail allotment in oversubscribed IPOs is done by computerised lottery, each valid application has an equal probability regardless of the number of lots applied for.

You can apply for Sudeep Pharma IPO through: (1) ASBA (Application Supported by Blocked Amount) via your bank's net banking or mobile app, (2) UPI-based application through your broker's app (Zerodha, Groww, Angel One, etc.), or (3) directly via your demat account. The amount is blocked in your account and deducted only upon allotment. Applications were accepted from Nov 21 to Nov 25, 2025.

The grey market premium (GMP) reflects unofficial pre-listing trading sentiment. For the latest Sudeep Pharma IPO GMP data, check the IPORise GMP page. Note: GMP is unofficial, speculative, and not a guaranteed indicator of listing price. Use it only as a sentiment signal alongside official subscription data.